Compare Organon Pharma Indonesia Tbk. (SCPI) vs Trikomsel Oke Tbk. (TRIO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Trikomsel Oke Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Trikomsel Oke Tbk. trades at Rp426 (market cap 11.08T). The key difference: Trikomsel Oke Tbk. is far larger — about 106.1× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | TRIO | |
|---|---|---|
Market Cap | 104.4B | 11.08T |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Trikomsel Oke Tbk.
PT Trikomsel Oke (the company) was established under its original name of PT Trikomsel Citrawahana based on Notarial Deed No. 11 dated August 21, 1996 of Mrs. Liliana Indrawati Tanuwidjaja, S.H.The Companys articles of association has been amended several times, most recently by notarial deed No. 25 of Fathiah Helmi, S.H., dated Oct 29, 2008, concerning among others, the change in the Company’s authorized stock and paid-up capital
Read more on TRIO →
